CURRICULUM VITAE
Dennis W Jay, PhD, DABCC, FACB
Department of Pathology
262 Danny Thomas Place
Memphis, TN 38105
Phone: 901-595-3156
e-mail: Dennis.Jay@stjude.org

Education
  • BS (Chemistry), 1978, Southwest Missouri State University.
  • MA Candidate (Analytical Chemistry), 1978-1981, University of Missouri-Columbia.
  • PhD (Clinical Chemistry), 1986, University of Health Sciences/The Chicago Medical School.
  • Postdoctoral fellowship in Clinical Chemistry, 1986-1988, Medical College of Virginia.
Employment History
  • 2002 - present, Technical Director - Clinical Chemistry/Laboratory Informatics, St. Jude Children's Research Hospital, Memphis, TN.
  • 1998 - 2002, Technical Director, American Association of Bioanalysts Proficiency Testing Service, Brownsville, TX.
  • 1997 - present, President, Jay Clinical Services, L.L.C., Berger, MO; Brownsville, TX; Memphis, TN.
  • 1990 - 1997, Clinical Chemist, Central Texas Veterans Health Care System, Temple, TX.
  • 1997, Visiting Lecturer, Baylor University, Waco, TX. 1994 - 1997, Adjunct Instructor, University of Mary Hardin-Baylor, Belton, TX.
  • 1992 - 1997, Assistant Professor, Department of Pathology and Laboratory Medicine, Texas A&M University College of Medicine, Temple, TX.
  • 1991 - 1997, Clinical Faculty Member, Medical Laboratory Technologist program, Temple Junior College, Temple, TX.
  • 1991 - 1997, Clinical Faculty Member, Program in Clinical Laboratory Science, Scott and White Clinic, Temple, TX.
  • 1989 - 1990, Technical Director, SciCor, Inc., Indianapolis, IN.
  • 1988 - 1989, Director, Clinical Chemistry/Toxicology, Sparrow Hospital, Lansing, MI.
  • 1988 - 1989, Technical Consultant, Laboratory of Clinical Medicine, Lansing, MI.
Certification
  • American Board of Clinical Chemistry Certification, 1991.
Professional Affiliations
  • American Chemical Society, 1980
    Chair-Elect, 1994; Chair, 1995; Councilor, 1996-1997; Heart O' Texas Section.
  • Phi Lambda Upsilon (Honorary chemical fraternity), 1980.
  • American Association for Clinical Chemistry, 1981.
  • American Association for the Advancement of Science, 1981.
  • New York Academy of Sciences, 1989.
  • College of American Pathologists, Inspector No. 903231, 1991.
  • American Society of Clinical Pathologists, 1995.
  • American Association of Bioanalysts, 1999
    Chair, Southern Region 2005-7, President-Elect 2007, President 2008,
    Secretary-Treasurer 2009.
  • Fellow, National Academy of Clinical Biochemistry, 2001.
Honors and Awards
  • Regent's Scholarship, Southwest Missouri State University, 1971.
  • Student travel grant to the Symposium on Advanced Analytical Concepts for the Clinical Laboratory, Knoxville, TN, AACC, 1984.
  • Outstanding performance award, North Chicago VA Hospital, 1985-1986; Central Texas Veterans Health Care System, 1991-1996.
  • Outstanding Lecturer, Scott & White Program in Clinical Laboratory Science, 1994-1995.
  • Outstanding Clinical Teacher, Scott & White Pathology Residents, 1994-1995.
  • Nominee for Laboratorian of the Year, Advance Magazine, 1997.
  • Health Care Financing Administration Regional Administrator's Citation, 2001.
Publications
  1. Halfman CJ, Wong FCL, Jay DW. Solvent Perturbation Fluorescence Immunoassay Technique. Anal Chem 1985;57:1928-1930.
  2. Halfman CJ, Dowe RJ, Jay DW, Schneider AS. The Effect of Dodecyl Sulfate on Immunoglobulin Hapten Binding. Mol Immunol 1986;23:943-949.
  3. Halfman CJ, Jay DW. Homogeneous, Micelle Quenching Fluorescent-Labeled Immunoassay for Detecting Amphetamine in Urine. Clin Chem 1986;32:1677-1681.
  4. Jay DW. "A Homogeneous Micelle-Quenching Fluorescence Immunoassay for Detection of Amphetamine in Urine Samples." PhD Thesis, University of Health Sciences/The Chicago Medical School, 1986.
  5. Jay DW, Miller WG. Evaluation of Fetal Lung Maturity by a Fluorescence Polarization Method and Comparison to the L/S Ratio. (Abstract) Clin Chem 1987;33:901.
  6. Jay DW, Miller WG. Sensitive Quantitation of Alkaline Phosphatase Isoenzymes by Electrophoresis on Lectin-Containing Agarose. (Abstract) Clin Chem 1988;34:1290.
  7. Jay DW. Macro Creatine Kinase Co-migrating with CK-MB on Electrophoresis. Clin Chem 1989;34:1920.
  8. Provasek D, Jay DW. Bichromatic Determination of Hemoglobin on the Hitachi 717. (Abstract) Clin Chem 1992;38:942.
  9. Jay DW, Provasek D. Correction of Hemolysis Interference for Selected Analytes on the Hitachi 717. (Abstract) Clin Chem 1992;38:1026.
  10. Jay DW, Provasek D. Characterization and Mathematical Correction of Hemolysis Interference for Selected Hitachi 717 Assays. Clin Chem 1993;39:1804-10.
  11. Farmer L, Jay DW. Evaluation of the DuPont ACA Plus MCKMB Assay and Comparison to CK-MB by Helena REP Electrophoresis. (Abstract) Clin Chem 1994;40:1052.
  12. Ellison D, Vafaee S, Miller S, Jay DW. Bilirubin Interference in the GDS Theophylline Assay. (Abstract) Clin Chem 1994;40:1114.
  13. Brawn PN, Foster DM, Jay DW, Kuhl D, Speights VO, Johnson EH, Coffield KS, Lind ML, Karl R, Weaver B. Characteristics of Prostatic Infarcts and Their Effect on Serum Prostate-Specific Antigen and Prostatic Acid Phosphatase. Urology 1994;44:71-75.
  14. Jay DW, Lawrence L. Porphyrins, Hemoglobin and Myoglobin in Bishop ML, Duben-Engelkirk JL, Fody EP, Eds. Clinical Chemistry, 3rd ed., JB Lippincott, Philadelphia, pp. 501-518, 1996.
  15. Jay DW, Provasek D. Comparison of Troponin-T and Troponin-I. (Abstract) Clin Chem 1996;42:S147.
  16. Jay DW, Johnson EH. Correction of High Calcium Values on Beckman CX Analyzers. (Abstract) Clin Chem 1997;43:S166.
  17. Jay DW. Windows 95/NT Linear Regression Programs for Method Comparison. (Abstract) Clin Chem 1998;44:A61.
  18. Jay DW. Non-protein Nitrogen in Bishop ML, Duben-Engelkirk JL, Fody EP, Eds. Clinical Chemistry, 4th ed., JB Lippincott, Philadelphia, pp. 260-274, 2000.
  19. Jay DW. Differences in Whole Blood and Plasma Glucose. ASCP Tech Sample, Jan, 2001.
  20. Lambert L, Caban J, Jay DW. Interference in the Vitros CREA Method when Measuring Urine Creatinine on Samples Acidified with Acetic Acid. (Letter) Clin Chem 2004;50:1273-1274.
  21. Jay DW. Mining Patient Data to Perform Analyte Comparison for Multiple Analyzers. (Abstract) Arch Pathol Lab Med 2004;128:1114.
  22. Burgoyne LL, Jay DW, Bikhazi GB, Armendi AJ. Isosulfan Blue Causes Factitious Methemoglobinemia in an Infant. Paediatr Anaesth 2005;15:1116-1119.
  23. Miller WG, Gibbs EL, Jay DW, Pratt KW, Rossi B, Vojt CM, Whitehead P. Preparation and Testing of Reagent Water in the Clinical Laboratory; Approved Guideline -- Fourth Edition. CLSI document C3-A4. Clinical and Laboratory Standards Institute, Wayne, PA, 2006.
  24. Hayden RT, Patterson DJ, Jay DW, Cross C, Dotson P, Possel RE, Srivastava DK, Mirro J, Shenep JL. Computer-Assisted Bar-Coding System Significantly Reduces Clinical Laboratory Specimen Identification Errors in a Pediatric Oncology Hospital. J Pediatr 2008;152:219-24.
  25. Jay DW, Onciu M. Comparison of the Sebia Capillarys2 and Primus Ultra2 Systems for Hemoglobin Identification and Quantitation. (Abstract) Clin Chem 2008;54:A31.
  26. Pestina TI, Hargrove PW, Jay D, Gray JT, Boyd KM, Persons DA. Correction of Murine Sickle Cell Disease Using gamma-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin. Mol Ther 2009;17:245-52.
  27. Jay DW. Method Comparison: Where Do We Draw the Line? Clin Chem Lab Med 2011;49:1089-1090.
  28. Hankins JS, McCarville MB, Rankine-Mullings A, Reid ME, Lobo CL, Moura PG, Ali S, Soares DP, Aldred K, Jay DW, Aygun B, Bennett J, Kang G, Goldsmith JC, Smeltzer MP, Boyett JM, Ware RE. Prevention of Conversion to Abnormal Transcranial Doppler with Hydroxyurea in Sickle Cell Anemia: A Phase III International Randomized Clinical Trial. Am J Hematol 2015;90:1099-105.
« Back